首页> Multiple sclerosis (Houndmills, Basingstoke, England)> Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS.

Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS.

导出 OA

翻译打印收藏纠错

第一作者： Marcus,W Koch

第一单位： Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada/Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

作者： Marcus,W Koch ^[1] ; Jop,Mostert ^[2] ; Pavle,Repovic ^[3] ; James D,Bowen ^[3] ; Eva,Strijbis ^[4] ; Bernard,Uitdehaag ^[4] ; Gary,Cutter ^[5]

作者单位： Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada/Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada. ^[1] Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands. ^[2] Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA. ^[3] Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands. ^[4] Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL, USA. ^[5]

关键词 MRI Secondary progressive MS disability health-related quality of life outcome measures

医学主题词残疾鉴定(Disability Evaluation);人类(Humans);多发性硬化(Multiple Sclerosis);多发性硬化, 慢性进行性(Multiple Sclerosis, Chronic Progressive);神经心理学测验(Neuropsychological Tests);生活质量(Quality of Life);步行(Walking)

DOI 10.1177/13524585211063623

PMID 34965774

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交